Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,358 | -8,175 | -6,356 | -3,655 | -15,309 |
| Depreciation Amortization | 1,075 | 787 | 498 | 300 | 751 |
| Accounts receivable | 1,145 | 2,203 | 494 | 1,101 | -1,683 |
| Other Working Capital | 292 | -147 | -1,098 | 1,327 | -2,514 |
| Other Operating Activity | -627 | -1,671 | 135 | -953 | 4,187 |
| Operating Cash Flow | $-8,473 | $-7,003 | $-6,327 | $-1,880 | $-14,568 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -462 | -655 | -659 | -611 | -1,161 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 26,037 |
| Other Investing Activity | 4 | -4 | -4 | -4 | 207 |
| Investing Cash Flow | $-458 | $-659 | $-663 | $-615 | $25,083 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -407 | -392 | -307 | -200 | -588 |
| Financing Cash Flow | $-407 | $-392 | $-307 | $-200 | $-588 |
| Exchange Rate Effect | 252 | 185 | 237 | 60 | -212 |
| Beginning Cash Position | 16,393 | 16,393 | 16,393 | 16,393 | 6,678 |
| End Cash Position | 7,307 | 8,524 | 9,333 | 13,758 | 16,393 |
| Net Cash Flow | $-9,086 | $-7,869 | $-7,060 | $-2,635 | $9,715 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,473 | -7,003 | -6,327 | -1,880 | -14,568 |
| Capital Expenditure | -706 | -660 | -664 | -615 | -1,161 |
| Free Cash Flow | -9,179 | -7,663 | -6,991 | -2,495 | -15,729 |